• 湿润烧伤膏治疗糖尿病患者足部低温烫伤疗效观察
  • Observation on the Clinical Efficacy of Moist Exposed Burn Ointment (MEBO) in the Treatment of Low-temperature Scalds in Patients with Diabetes
  • 钟晓光.湿润烧伤膏治疗糖尿病患者足部低温烫伤疗效观察[J].中国烧伤创疡杂志,2017,(3):165~168.
    DOI:
    中文关键词:  湿润烧伤膏  糖尿病  低温烫伤  创面  疗效
    英文关键词:MEBO  Diabetes  Low-temperature scalds  Wounds  Curative effect
    基金项目:
    作者单位
    钟晓光 遵义医学院/大连医科大学附属第二医院钻石湾院区创面修复科 
    摘要点击次数: 2578
    全文下载次数: 4502
    中文摘要:
          目的 观察?探讨湿润烧伤膏治疗糖尿病患者足部低温烫伤的临床疗效?方法 将2013 年8 月—2016 年12 月大连医科大学附属第二医院钻石湾院区创面修复科收治的60 例足部低温烫伤的糖尿病患者随机分为治疗组(30 例) 与对照组(30 例), 其中治疗组患者创面采用湿润烧伤膏换药治疗, 对照组患者创面采用雷夫诺尔药纱换药治疗, 对比观察两组患者的创面疼痛程度?创面愈合时间及创面感染率?结果 治疗组创面愈合时间为(37.70±2.93) d, 明显短于对照组的(42.27±5.34) d, 两组对比, t'= 4.109, P<0.01, 差异具有统计学意义; 治疗过程中, 治疗组无1 例患者出现创面感染, 无明显疼痛者20 例?轻度疼痛者8 例?中度疼痛者2例, 而对照组有5 例患者出现创面感染, 无明显疼痛者12 例?轻度疼痛者14 例?中度疼痛者4 例, 两组对比,P 均<0.05, 差异具有统计学意义?结论 湿润烧伤膏治疗糖尿病患者足部低温烫伤创面, 可有效缓解创面疼痛, 缩短创面愈合时间, 降低创面感染发生率, 疗效显著, 值得临床推广应用?
    英文摘要:
          Objective: To observe and explore the clinical efficacy of Moist Exposed Burn Ointment (MEBO) in the treatment of low-temperature scalds in patients with diabetes. Methods: Sixty diabetic patients with foot low-temperature scalds admitted into The Wound Repair Department of The Second Hospital of Dalian Medical University (zuanshiwan) between August 2013 and December 2016 were randomly divided into a treatment group(n=30) and a control group (n=30). Patients in the treatment group were treated with the dressing change of MEBO while patients in the control group were treated with the dressing change of Ethacridine Lactate-impregnated gauze, followed by the observation on and comparison of wound pain severity, wound healing time and wound infection rate between the two groups. Results: The wound healing time in the treatment group was (37.70_x001f_±2.93)d, remarkably being shorter than (42.27±5.34)d in the control group, and the comparison showed statistically significant difference, t’=4.109,P<0.01. During the treatment course, in the treatment group there was no patients who developed wound infection, 20 patients suffered inconspicuous pain, 8 patients suffered mild pain and 2 patients suffered moderate pain, while in the control group 5 patients developed wound infection, 12 patients suffered inconspicuous pain, 14 patients suffered mild pain and 4 patients suffered moderate pain, and the comparison between the two groups showed statistically significant difference (P<0.05). Conclusion: MEBO should be promoted in the clinical practice of treating foot low-temperature scalds of diabetic patients in that it can effectively relieve wound pain, shorten wound healing time and reduce the incidence of infection.